Laddar...

FVIIa as used pharmacologically is not TF dependent in hemophilia B mice

Activated factor VII is approved for treating hemophilia patients with autoantibodies to their factor IX or FVIII; however, its mechanism of action remains controversial. Some studies suggest that FVIIa requires tissue factor (TF) for function and that the reason for the high dose requirement is tha...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Feng, Dengmin, Whinna, Herbert, Monroe, Dougald, Stafford, Darrel W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2014
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3954056/
https://ncbi.nlm.nih.gov/pubmed/24425804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-522987
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!